Standalone September quarter revenue up 11%, profit after tax up 9% year on year
ABBOTINDIA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.5 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
On a standalone basis for the quarter ended September 30, 2026, revenue from operations rose 11.0% to Rs 1,951.01 crore from Rs 1,757.15 crore, while profit after tax rose 9.2% to Rs 453.45 crore from Rs 415.27 crore. Standalone half-year revenue was Rs 3,764.69 crore, up 7.7%, and profit after tax was Rs 881.97 crore, up 12.9%. Half-year operating cash flow was positive at Rs 658.97 crore, and the review report had no qualifications.
Positive: revenue and profit grew year on year, cash flow remained strong, and the review had no qualifications, supporting shareholder sentiment.
The filed figures for this quarter have not reached us in XBRL yet, so there is nothing to compute here; the read above is the AI's, from the document. The table appears the moment the figures land.